Fusion Antibodies PLC (FAB)

Currency in GBP
15.75
+1.25(+8.62%)
Closed·
FAB Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
FAB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14.6816.40
52 wk Range
2.8017.00
Key Statistics
Bid/Ask
14.00 / 16.00
Prev. Close
15.75
Open
14.5
Day's Range
14.68-16.4
52 wk Range
2.8-17
Volume
1.15M
Average Volume (3m)
1.16M
1-Year Change
377.27%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FAB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Fusion Antibodies PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Fusion Antibodies PLC Company Profile

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. It serves pharmaceutical, biotech, veterinary, diagnostic, and life science research companies. It has a collaboration agreement with the National Cancer Institute for the use of OptiMAL for discovery of novel antibodies against targets selected by NCI. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.

Compare FAB to Peers and Sector

Metrics to compare
FAB
Peers
Sector
Relationship
P/E Ratio
−10.9x−3.2x−0.5x
PEG Ratio
−0.15−0.010.00
Price/Book
16.4x1.4x2.6x
Price / LTM Sales
9.6x3.6x3.3x
Upside (Analyst Target)
-58.5%40.3%
Fair Value Upside
Unlock21.0%4.7%Unlock

Earnings

Latest Release
May 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
753.00K / 800.00K
EPS Revisions
Last 90 days

FAB Income Statement

People Also Watch

4.30
HAMA
-2.71%
0.15
UFO
0.00%
0.04
BZT
0.00%
0.7750
GST
0.00%

FAQ

What Stock Exchange Does Fusion Antibodies Trade On?

Fusion Antibodies is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for Fusion Antibodies?

The stock symbol for Fusion Antibodies is "FAB."

What Is the Fusion Antibodies Market Cap?

As of today, Fusion Antibodies market cap is 17.90M.

What Is Fusion Antibodies's Earnings Per Share (TTM)?

The Fusion Antibodies EPS (TTM) is -0.02.

From a Technical Analysis Perspective, Is FAB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Fusion Antibodies Stock Split?

Fusion Antibodies has split 0 times.

How Many Employees Does Fusion Antibodies Have?

Fusion Antibodies has 27 employees.

What is the current trading status of Fusion Antibodies (FAB)?

As of 14 Aug 2025, Fusion Antibodies (FAB) is trading at a price of 15.75, with a previous close of 15.75. The stock has fluctuated within a day range of 14.68 to 16.40, while its 52-week range spans from 2.80 to 17.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.